Code |
Title |
Fellow |
Organisation |
Abstract |
Final Summary |
PCL/24/01 |
Investigating BRAF driven systemic neutrophilia and clinical utility of neutrophil blockade in colorectal cancer |
Dr Mark White |
University of Glasgow |
PCL/24/01 |
Project Active |
PCL/24/03 |
Investigating the Role of Fibrosis Activity in Diabetic Cardiomyopathy |
Dr Shruti Joshi |
University of Edinburgh |
PCL/24/03 |
Project Active |
PCL/24/04 |
Characterising postoperative trajectory following renal transplantation using nationally linked healthcare data |
Dr Stephen Knight |
University of Glasgow |
PCL/24/04 |
Project Active |
PCL/24/06 |
Endothelial Dysfunction as a Mechanism of Vascular Injury & Increased Cardiovascular Disease Risk in Large Vessel Vasculitis |
Dr Dan Pugh |
University of Edinburgh |
PCL/24/06 |
Project Active |
PCL/23/03 |
Novel diagnostics in gynaecology oncology |
Dr Neil Ryan |
University of Edinburgh |
PCL/23/03 |
Project Active |
PCL/23/04 |
The effect of DNA damage on PARylation and extrachromosomal DNA (ecDNA) dynamics |
Dr Karin Purshouse |
University of Edinburgh |
PCL/23/04 |
Project Active |
PCL/23/07 |
The minor spliceosome in health and disease |
Dr Nic Robertson |
University of Edinburgh |
PCL/23/07 |
Project Active |
PCL/22/01 |
Preventing Unintended Pregnancy in the Post-COVID-19 Era. |
Dr John Reynolds-Wright |
University of Edinburgh |
PCL/22/01 |
Project Active |
PCL/22/03 |
The role of cancer associated fibroblast heterogeneity in determining metastatic patterns in pancreatic and oesophageal adenocarcinoma. |
Dr Stephan Dreyer |
University of Glasgow |
PCL/22/03 |
PCL/22/03 Research Project Briefing |
PCL/22/05 |
The relationship between the tumour phenotype, JAK/STAT signalling, systemic inflammation, body composition and survival in patients with operable colorectal cancer. |
Dr Ross Dolan |
University of Glasgow |
PCL/22/05 |
Project Active |
PCL/22/07 |
Defining the prevalence of adverse host characteristics and their influence on prehabilitation response. |
Dr Katrina Knight |
University of Glasgow |
PCL/22/07 |
Project Active |
PCL/21/01 |
Using and improving Scotland’s care home data: a mixed methods programme of data linkage research and consensus gathering |
Dr Jenni Burton |
University of Glasgow |
PCL/21/01 |
Project Active |
PCL/21/03 |
The role of NFκB signalling in immune checkpoint expression and myeloid cell function in colorectal cancer |
Dr Norman Galbraith |
University of Glasgow |
PCL/21/03 |
Project Active |
PCL/21/05 |
Cardiovascular risk in early onset hypogonadism. |
Dr Angela Lucas-Herald |
University of Glasgow |
PCL/21/05 |
Project Active |
PCL/20/01 |
Temporal dynamics of multimorbidity and medication use with mental illness and dementia: an investigation in NHS Scotland routinely collected data and the Lothian Birth Cohort 1936 |
Dr Lucy Stirland |
University of Edinburgh |
PCL/20/01 |
PCL/20/01 Research Project Briefing |
PCL/20/02 |
The Role of Apelin and Apelin Receptor as therapeutic targets in lung inflammation and injury |
Dr Simon Biddie |
University of Edinburgh |
PCL/20/02 |
Project Active |
PCL/20/05 |
Single-cell transcriptomic analysis of anaesthetic effects on neuronal and non-neuronal cell populations modulating CNS vulnerability |
Dr Zoeb Jiwaji |
University of Edinburgh |
PCL/20/05 |
PCL/20/05 Research Project Briefing |
PCL/20/10 |
Defining the bi-directional relationship between cancer and kidney disease |
Dr Jennifer Lees |
University of Glasgow |
PCL/20/10 |
PCL/20/10 Research Project Briefing |
PCL/19/01 |
Precision treatment and drug repurposing to reduce endometriosis-associated pain in women |
Dr Lucy Whittaker |
University of Edinburgh |
PCL/19/01 |
PCL/19/01 Research Project Briefing |
PCL/18/03 |
Non-invasively quantifying, understanding and reversing myocardial fibrosis in renal failure |
Dr Elaine Rutherford |
University of Glasgow |
PCL/18/03 |
PCL/18/03 Research Project Briefing |
PCL/18/05 |
Derivation of a hospital episode frailty index from electronic patient records: understanding the role of frailty in health outcomes for older hospital patients in Scotland |
Dr Atul Anand |
University of Edinburgh |
PCL/18/05 |
PCL/18/05 Research Project Briefing |
PCL/18/06 |
Manipulating the immune microenvironment in Malignant Pleural Mesothelioma |
Dr Clare Rooney |
University of Glasgow |
PCL/18/06 |
Project Active |
PCL/17/01 |
Circuit-level pathophysiology and amelioration of NMDAR-channelopathies in two new rat models |
Dr Katie Marwick |
University of Edinburgh |
PCL/17/01 |
Project Active |
PCL/17/03 |
Characterising the role of CXCR2 signalling in colorectal cancer metastasis |
Dr Colin Steele |
University of Glasgow |
PCL/17/03 |
PCL/17/03 Research project briefing |
PCL/17/04 |
Combined magnetic resonance coronary angiography and positron emission tomography in patients with coronary artery disease |
Dr Michelle Williams |
University of Edinburgh |
PCL/17/04 |
PCL/17/04 Research Project briefing |
PCL/17/07 |
Identifying Novel Opportunities for Translational Research, Precision Medicine and Drug Repurposing in Cardiovascular Disease Using Pharmacoepidemiology, Genetic Epidemiology and Bioinformatics |
Dr Ify Mordi |
University of Dundee |
PCL/17/07 |
Project Active |
PCL/17/10 |
Improving predictions of prognosis in Parkinson’s: moving from intensive small-scale studies to large and reliable routinely collected datasets |
Dr Angus Macleod |
University of Aberdeen |
PCL/17/10 |
PCL/17/10 Research Project briefing |